HPC Biosciences Ltd Stock Price Today (NSE: HPBL)
Fundamental Score
HPC Biosciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
HPC Biosciences Ltd share price today is ₹180.00, up +0.25% on NSE/BSE as of 7 August 2026. HPC Biosciences Ltd (HPBL) is a Small-cap company in the Packaging sector with a market capitalisation of ₹205.91 (Cr). The 52-week high for HPBL share price is ₹284.45 and the 52-week low is ₹140.10. At a P/E ratio of 8.84x, HPBL is currently trading below its industry average P/E of 21.40x. The company has a Return on Equity (ROE) of 32.93% and a debt-to-equity ratio of 3.00.
HPC Biosciences Ltd Share Price Chart — NSE/BSE Historical Performance
HPC Biosciences Ltd share price chart: -10.13% return over the past month. 52-week high ₹284.45, 52-week low ₹140.10.
HPC Biosciences Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹183.60 | ₹187.00 | ₹175.20 | ₹180.00 | 7.59K (Cr) | |
| ₹177.25 | ₹183.95 | ₹175.00 | ₹179.55 | 4.55K (Cr) | |
| ₹186.60 | ₹189.30 | ₹176.50 | ₹177.25 | 9.03K (Cr) | |
| ₹185.00 | ₹189.45 | ₹180.05 | ₹182.50 | 7.06K (Cr) | |
| ₹183.00 | ₹187.50 | ₹179.00 | ₹185.15 | 2.19K (Cr) | |
| ₹183.45 | ₹184.40 | ₹175.00 | ₹182.75 | 3.89K (Cr) | |
| ₹183.00 | ₹188.00 | ₹176.00 | ₹177.00 | 8.34K (Cr) | |
| ₹182.85 | ₹187.40 | ₹182.85 | ₹184.30 | 673.00 (Cr) | |
| ₹179.65 | ₹182.90 | ₹176.00 | ₹182.85 | 1.56K (Cr) | |
| ₹183.05 | ₹188.00 | ₹176.00 | ₹179.65 | 6.56K (Cr) |
HPC Biosciences Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹183.00 | ₹189.45 | ₹175.00 | ₹180.00 | -1.64% | |
| ₹200.05 | ₹212.60 | ₹171.55 | ₹182.75 | -8.65% | |
| ₹251.50 | ₹259.00 | ₹196.00 | ₹201.50 | -19.88% | |
| ₹267.00 | ₹284.45 | ₹230.00 | ₹251.50 | -5.81% | |
| ₹158.10 | ₹278.50 | ₹158.00 | ₹267.05 | +68.91% | |
| ₹180.10 | ₹190.00 | ₹158.00 | ₹158.10 | -12.22% | |
| ₹153.15 | ₹199.85 | ₹142.30 | ₹179.10 | +16.94% | |
| ₹170.00 | ₹186.00 | ₹140.10 | ₹153.85 | -9.50% | |
| ₹200.95 | ₹200.95 | ₹156.10 | ₹172.20 | -14.31% | |
| ₹155.05 | ₹206.50 | ₹150.00 | ₹192.50 | +24.15% | |
| ₹160.15 | ₹194.45 | ₹150.00 | ₹163.55 | +2.12% | |
| ₹170.10 | ₹180.00 | ₹157.50 | ₹166.00 | -2.41% |
AI Research Briefing
Powered by Gemini · 2026-04-13
High-risk micro-cap leveraged to Indian packaging growth, but financials and past behavior raise serious concerns.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. The most recent news relates to the broader packaging industry and not HPC Biosciences specifically.
CORE STORY (THE REAL GAME)
- Indian packaging industry growth
- Strong YoY profit growth [cite: brief]
- Shift towards organized retail and e-commerce
- Significant order wins
- Debt reduction
- Improvement in FCF
- Micro/SME cap - liquidity risk
- High Debt/Equity ratio of 2.96 [cite: brief]
- Negative Free Cash Flow of ₹-171.58 Cr over 5 years [cite: brief]
FII increased stake to 4.5% (Δ 4.43%) [cite: brief]. DII holding steady at 4.8% (Δ 0.0%) [cite: brief]. Promoter holding remains high at 75% [cite: brief].
The Indian packaging industry is projected to grow strongly, driven by rising consumption and e-commerce.
Profit not converting to cash. Free Cash Flow 5Y: ₹-171.58 Cr [cite: brief]
If HPC Biosciences can manage its debt and capitalize on industry growth, there is potential for significant upside. However, the risks are substantial, and a turnaround is not guaranteed.
Primary Thesis Risk
Inability to service debt amidst slowing growth could lead to collapse.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
HPC Biosciences Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
HPC Biosciences Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of HPBL across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (32.93%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (19.42%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 8.84 vs Industry: 21.40)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (65.64%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (16.77%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (105.91% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (27.13% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (16.67% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (75.00%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Elevated Debt Levels (D/E: 3.00)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Negative Free Cash Flow (₹-173.08 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 9.29%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
HPC Biosciences Ltd vs Packaging Peers
Peer Comparison - Packaging
Compare HPC Biosciences Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
HPC Biosciences LtdHPC Biosciences...Selected✓ HPBL • 526717 | 63.7/100 | ₹180.00₹180 | ₹205.91₹205.91 | 8.84Average 8.8 Average | 32.93%Excellent 32.93% Excellent | 19.42%Good 19.42% Good | 3.00Poor 3.0 Poor | 16.67%Excellent 16.67% Excellent | 105.91%Excellent 105.91% Excellent | 0.52% |
EPL LtdEPL Ltd... EPL • 500135 | 39.4/100 | ₹222.42₹222 | ₹7636.31₹7636.31 | 18.57Average 18.6 Average | 15.77%Good 15.77% Good | 17.84%Good 17.84% Good | 0.34Excellent 0.3 Excellent | 10.44%Good 10.44% Good | 9.03%Good 9.03% Good | 2.10% |
Alamos Gold IncAlamos Gold Inc... AGI • 500187 | 67.2/100 | ₹709.25₹709 | ₹4496.50₹4496.50 | 12.63Average 12.6 Average | 15.80%Good 15.80% Good | 19.60%Good 19.60% Good | 0.10Excellent 0.1 Excellent | 32.37%Excellent 32.37% Excellent | 16.17%Excellent 16.17% Excellent | 1.01% |
Polyplex Corporation LimitedPolyplex Corpor... POLYPLEX • 524051 | 23.3/100 | ₹1105.30₹1105 | ₹3350.33₹3350.33 | 74.53Average 74.5 Average | 1.12%Poor 1.12% Poor | 0.98%Poor 0.98% Poor | 0.22Excellent 0.2 Excellent | -38.53%Poor -38.53% Poor | 7.58%Good 7.58% Good | 1.26% |
Xpro India LtdXpro India Ltd... XPROINDIA • 590013 | 35.4/100 | ₹1393.20₹1393 | ₹3264.54₹3264.54 | 170.11Average 170.1 Average | 2.80%Poor 2.80% Poor | 3.78%Poor 3.78% Poor | 0.43Excellent 0.4 Excellent | 18.11%Excellent 18.11% Excellent | 6.41%Good 6.41% Good | 0.14% |
Uflex LimitedUflex Limited... UFLEX • 500148 | 35/100 | ₹470.65₹471 | ₹3181.26₹3181.26 | 9.60Average 9.6 Average | 4.27%Poor 4.27% Poor | 7.03%Poor 7.03% Poor | 1.25Average 1.3 Average | -17.07%Poor -17.07% Poor | 11.62%Good 11.62% Good | 0.68% |
TCPL Packaging LtdTCPL Packaging ... TCPLPACK • 523301 | 50.1/100 | ₹3153.40₹3153 | ₹3018.93₹3018.93 | 28.34Average 28.3 Average | 15.56%Good 15.56% Good | 17.92%Good 17.92% Good | 0.83Good 0.8 Good | 26.05%Excellent 26.05% Excellent | 13.95%Good 13.95% Good | 0.76% |
Jindal Poly Films LtdJindal Poly Fil... JINDALPOLY • 500227 | 13.2/100 | ₹633.30₹633 | ₹2952.07₹2952.07 | — — | 2.15%Poor 2.15% Poor | 5.36%Poor 5.36% Poor | 0.84Good 0.8 Good | -28.49%Poor -28.49% Poor | 8.52%Good 8.52% Good | 0.87% |
Mold Tek Packaging LtdMold Tek Packag... MOLDTKPAC • 533080 | 38/100 | ₹672.20₹672 | ₹2281.03₹2281.03 | 31.57Average 31.6 Average | 10.88%Average 10.88% Average | 13.32%Average 13.32% Average | 0.31Excellent 0.3 Excellent | 8.06%Good 8.06% Good | 13.11%Good 13.11% Good | 0.58% |
Cosmo First LtdCosmo First Ltd... COSMOFIRST • 508814 | 42.6/100 | ₹892.30₹892 | ₹2172.84₹2172.84 | 13.49Average 13.5 Average | 10.45%Average 10.45% Average | 11.23%Average 11.23% Average | 1.04Average 1.0 Average | -7.12%Poor -7.12% Poor | 9.75%Good 9.75% Good | 0.48% |
Huhtamaki India LtdHuhtamaki India... HUHTAMAKI • 509820 | 31/100 | ₹298.14₹298 | ₹1679.40₹1679.40 | 14.30Average 14.3 Average | 8.96%Poor 8.96% Poor | 11.98%Average 11.98% Average | 0.11Excellent 0.1 Excellent | 3.51%Average 3.51% Average | 0.05%Average 0.05% Average | 0.90% |
Top Packaging Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- EPL Ltd share price7636.31 Cr
- Alamos Gold Inc share price4496.50 Cr
- Polyplex Corporation Limited share price3350.33 Cr
- Xpro India Ltd share price3264.54 Cr
- Uflex Limited share price3181.26 Cr
HPC Biosciences Ltd Quarterly Performance
Latest quarterly metrics for HPBL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
16.77%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
65.64%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
105.91%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
16.67%
Compounded annual net profit growth over 5 years
HPC Biosciences Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for HPBL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
HPC Biosciences Ltd Financial Statements
Annual income statement, balance sheet and cash flow for HPC Biosciences Ltd (HPBL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for HPC Biosciences Ltd
About HPBL (HPC Biosciences Ltd)
HPC Biosciences Ltd is a pioneer in the design and manufacture of innovative packaging solutions tailored for the demanding needs of the biopharmaceutical industry. HPBL specialize...s in developing and producing high-performance containers and delivery systems, focusing on maintaining the integrity and efficacy of sensitive biological materials. Their product line encompasses a range of temperature-controlled packaging, including insulated shippers and phase change material (PCM) solutions, ensuring consistent and reliable temperature maintenance throughout the cold chain. Furthermore, HPBL is committed to sustainable practices, exploring biodegradable and recyclable materials to minimize environmental impact. They offer customized packaging solutions designed to meet specific product requirements, including various sizes, formats, and security features, guaranteeing product safety and security during transportation and storage. HPBL's core expertise lies in its ability to combine advanced materials science with precision engineering, producing packaging that exceeds industry standards. Their innovative approach includes integrating real-time monitoring capabilities, allowing for complete visibility of the package's environmental conditions throughout its journey. This integration of technology ensures that clients can track temperature, humidity, and other critical parameters, facilitating informed decision-making and mitigating potential risks. HPBL places a strong emphasis on research and development, consistently pushing the boundaries of packaging technology. They are dedicated to providing reliable and cost-effective solutions that address the evolving challenges faced by the biopharmaceutical sector. HPBL distinguishes itself through its commitment to quality and regulatory compliance, adhering to the most stringent global standards, including those set by the World Health Organization (WHO) and the International Safe Transit Association (ISTA). Their manufacturing processes are meticulously controlled, utilizing state-of-the-art equipment and employing rigorous quality assurance measures. HPBL works in close collaboration with its clients, providing technical support and expert guidance to ensure optimal packaging performance. This collaborative approach extends from initial design concepts to final product delivery, fostering long-term partnerships built on trust and mutual success. HPBL aspires to be the preeminent provider of packaging solutions, empowering the biopharmaceutical industry to deliver life-saving therapies worldwide.
Company Details
Key Leadership
Corporate Events
HPBL Share Price: Frequently Asked Questions
What is the current share price of HPC Biosciences Ltd?
HPC Biosciences Ltd (HPBL) trades at ₹180.00 on NSE and BSE. Market cap ₹205.91 (Cr). Educational data only.
What is the P/E ratio of HPC Biosciences Ltd?
HPC Biosciences Ltd has a P/E of 8.84x vs industry average 21.40x.
What is the Bull Run score for HPC Biosciences Ltd?
HPC Biosciences Ltd has a Bull Run score of 63.7/100 based on 25+ financial parameters.
Does HPC Biosciences Ltd pay dividends?
HPC Biosciences Ltd has a dividend yield of 0.52%. Past dividends don't guarantee future payments.
What is the ROE of HPC Biosciences Ltd?
HPC Biosciences Ltd has ROE of 32.93%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of HPC Biosciences Ltd?
HPC Biosciences Ltd has debt-to-equity of 3.00.
Is HPC Biosciences Ltd a good investment?
Bull Run gives HPC Biosciences Ltd a score of 63.7/100. This is not investment advice — consult a SEBI-registered advisor.